Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722206 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
CD ROMAdd to Basket
Electronic (PDF)Add to Basket
Site LicenseAdd to Basket
EnterprisewideAdd to Basket

<< Back to Search Results



Analyzing the Indian Pharmaceutical Industry
Aruvian's R'search, Nov 2009, Pages: 75


  Description  
  Table of Contents  
  Summary  
  Companies Mentioned  
    
   
 Enquire before Buying  
 Send to a Friend  

The Indian Pharmaceutical Industry has come a long way from waiting for imports of bulk drugs from global majors for re processing to becoming an industry which is driving product development and breaking new grounds in medicine research worldwide. This transformation can be better gauged in terms of volume numbers where in the industry which was earlier stagnating is now expected to touch a turnover of INR250 billion ($5.7 billion) at the end of the 10th Five Year Plan (2002-2007). Part of this amazing growth story will be propelled by capital investments of around INR100 billion ($2.3 billion), most of which have already been committed to the Government of India.

The Indian pharmaceutical industry has a unique amalgamation of three critical factors which make it so attractive for investment thereby adding impetus to growth.

- The process patent regime
- Price controls
- Exemptions to Small Scale Industries (SSIs)

The commitment to infrastructure development, technological competency augmentation and a wide array of products has boosted the industry to already achieve the $4 billion mark.

The implementation of Good Manufacturing Practices has become a further supplement to the industry now producing bulk drugs for all the major therapy segments which are the most in demand. The competencies developed in India in organic synthesis & process engineering have helped derive the most cost effective solutions in time efficient scales and compliant with high quality standards. An important outcome of this was India’s low cost production of anti-retrovirals for export to humanitarian and international organizations in needy African countries which brought global recognition and acceptance of the industry as a major player in the global drug producing nations.

Aruvian's R'search’s report on Analyzing the Indian Pharmaceutical Industry is an extensive outlook on the industry which explains the basics of the industry by examining the participants which come under the purview of the industry. The report presents a complete synopsis on the Indian pharmaceutical market and its present demographics wherein the report also presents the turnover volumes currently being handled by the industry.

The report further breaks down this volume analysis by product segment as well as the expected turnovers as per the life long therapy segments which are prevalent in India. The report explores the progressive R&D initiatives which have been carried out in the industry in order to boost its own production, invention as well as to improve on the quality of products being presently marketed.

The cost competitive advantage of the Indian Pharmaceutical Industry is explained in this report along with the patterns of consumer behavior which indicates further growth sustenance in the industry. The report also analyzes certain market developments which have supplanted growth till now and the drivers of growth in the Indian Pharmaceutical Industry.

An important area of import/export balances is also explained in detail in this report where the achievements of the industry are highlighted in making the turnaround from a net importer to a net exporter. The report further applies three important analyses as the SWOT, PEST, and Porter’s Five Forces Strategy analysis to test the Indian Pharmaceutical Industry’s competence.

As the industry is a continuous growth engine the report provides an insight into the investment infusion structure currently prevalent in the industry and the further opportunity areas. The report builds a profiling of the major contributors in the Industry and analyses their relative financial performances, product portfolios, business strategies etc. The report also presents a future perspective of the Industry which is an indicative of the vast potential and growth opportunities available ahead for the Indian pharmaceutical industry.



Customers who bought this item also bought

Analyzing the Indian Retail Industry

Indian Pharmaceutical Industry

Indian Pharmaceutical Industry: Strategies, Trends and Opportunities

Pharmaceutical Industry in India - PEST Framework Analysis

Analyzing the Indian Financial Services Industry

Analyzing the Indian Steel Industry

Indian Biopharmaceuticals Industry Report

Indian Defence Industry Report

Strategic Restructuring for the Indian Steel Industry

Indian Pharmaceutical Industry

The Indian Pharmaceutical Industry 2009: Diversification, Expansion & Ambitions

The Indian Pharmaceutical Industry: Expansion & Ambitions + Indian Pharma Industry Tracker



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds